Resources for You and Your Patients
Valeant provides a wealth of resources for both you and your patients.
Click any of the following links to learn more:
- A rebate on your copay for your LACRISERT® prescription
- Access to the Valeant Patient Assistance Program
- A resource to learn more about LACRISERT®
- A list of useful Web sites about Dry Eye
LACRISERT® documents are available for download for you and your patients:
- LACRISERT® Patient Insertion Instructions
- LACRISERT® Spanish Patient Insertion Instructions
- LACRISERT® Clinical White Paper
If you would like to request free LACRISERT® samples for your patients, fill out the request form and either fax it or mail it as indicated on the form.
Indications and Usage
LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Important Safety Information
LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.
The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.